Stefan Michiels - Publications, H-index & Citations

Stefan Michiels

Department of Biostatistics and Epidemiology

85H指数

1.0K论文数

3.1W被引数

收录论文 256

发表时间

Correction: Identifying health conditions associated with an increased risk of pancreatic ductal adenocarcinoma at medium term in nationwide electronic health records of primary care physicians 更正：识别与全科医生全国电子健康记录中中期胰腺导管腺癌风险增加相关的健康状况

British Journal of Cancer

IF6.8

2026-08-31

OAAI

Elie Rassy; Suzette Delaloge; Yannis Slaouti; Thomas Pudlarz; Béranger Lekens; Alice Boilève; Stefan Michiels; Maryam Karimi

Development and internal validation of a clinical risk prediction model for pancreatic ductal adenocarcinoma in the UK Biobank 基于英国生物银行开发的胰腺导管腺癌临床风险预测模型及其内部验证

European Journal of Cancer

IF7.1

2026-04-28

PREAI

Elie Rassy; Suzette Delaloge; Thérèse Truong; Léa Bouteille; Thomas Pudlarz; Alice Boilève; Stefan Michiels; Maryam Karimi

Making sense of TILs: recommendations for morphological assessment of tumour-infiltrating lymphocytes in gastro-oesophageal carcinoma 理解TILs: 胃食管癌中肿瘤浸润淋巴细胞形态学评估的建议

Histopathology

IF4.1

2026-02-05

OAAI

Ylva A Weeda; Roberto Salgado; Filip van Herpe; Daniel Sur; Michael Vieth; Sherene Loi; Ahmad P Tafti; Hardas Alexandros; Akira I Hida; Amarpreet Bhalla; Andrey I Khramtsov; Anna Ehinger; Atsushi Tanaka; Balazs Acs; Caner Ercan; Cornelia M Focke; Daniel Ehinger; Dan Huang; Galina F Khramtsova; Haruto Nishida; Nianyi Li; Nickolas Littlefield; Sanna Steen; Selim Sevim; Shin Ichihara; Shinnosuke Morikawa; Stefan Michiels; Thomas Papathomas; Toshihiro Haga; Qiangqiang Gu; Weiqi Sheng; Hoel Kervadec; Hugo M Horlings; Francisco Sanchez-Vega; Yelena Y Janjigian; Myriam Chalabi; Hanneke W M van Laarhoven; Liudmila L Kodach; Sybren L Meijer

Robotic nipple-sparing mastectomy with immediate prosthetic reconstruction: A prospective study about 138 consecutive procedures 机器人保留乳头的乳房切除术联合即刻假体重建：一项关于138例连续手术的前瞻性研究

Annales de Chirurgie Plastique Esthetique

IF0.5

2026-01-01

OAAI

Lherm, M.; Chaltiel, D.; Roulot, A.; Leymarie, N.; Honart, J. -F; Rimareix, F.; Delaloge, S.; Michiels, S.; Sarfati, B.

Evaluating Breast Cancer Screening Consortium and MammoRisk plus polygenic risk score 313 for breast cancer risk prediction in UK Biobank 评估乳腺癌筛查联盟和MammoRisk plus多基因风险评分313对乳腺癌风险预测在英国生物银行中的应用

European Journal of Cancer

IF7.1

2025-11-06

PREAI

Elie Rassy; Suzette Delaloge; Mojgan Karimi; Thérèse Truong; Emilien Gauthier; Stéphane Ragusa; Damien Drubay; Paul Pharoah; Stefan Michiels; Maryam Karimi

Comprehensive radiotherapy quality assurance analysis from individual DICOM data in the HyptoG-01 phase 3 trial HyptoG-01 III期试验中基于个体DICOM数据的全面放射治疗质量保证分析

Radiotherapy and Oncology

IF5.3

2025-10-30

PREAI

Thomas Brion; Mamadou Balde; Rodrigue Allodji; Christine Rossier; Guillaume Auzac; Claire Petit; Pierre Maroun; Amandine Ruffier; David Pasquier; Stephanie Wong; Assia Lamrani; Marie Bergeaud; Guenael Dequeker; Sandrine Ducornet; Robabeh Ghodssighassemabadi; Stefan Michiels; Sofia Rivera

Adjusting for abiraterone-prednisone cross-over in de novo metastatic castration-sensitive prostate cancer: a post-hoc analysis of the PEACE-1 trial 调整阿比特龙-泼尼松交叉对原发转移性去势敏感前列腺癌的影响：PEACE-1试验的事后分析

European Journal of Cancer

IF7.1

2025-09-27

PREAI

Adrien Rousseau; Maryam Karimi; Stefan Michiels; Guilhem Roubaud; Xavier Maldonado; Stephane Supiot; Ray McDermott; Aude Flechon; Bertrand Tombal; Philippe Ronchin; Dominik Berthold; Jean-François Berdah; Gabriel Kacso; Gwenaelle Gravis; Fabio Calabro; Sophie Tartas; Xavier Muracciole; Helene Ribault; Karim Fizazi; Stéphanie Foulon

Acceptance of external control arms by HTA agencies: a review of oncology submissions in France, England, Germany and Norway from 2021 to 2023 HTA机构对外部对照的接受度：2021年至2023年法国、英格兰、德国和挪威肿瘤学提交案例的回顾

British Journal of Cancer

IF6.8

2025-09-12

PREAI

Matthias Monnereau; Jean-Pierre Delord; Stefan Michiels; Christophe Le Tourneau; Sebastien Marque; Louise Baschet; Thomas Filleron

Molecular analysis of lung adenocarcinomas from the SAFIR02-Lung cohort reveals new metastasis-associated copy-number alterations including frequent mutant-specific KRAS-allelic imbalance and identifies CDKN2A homozygous deletions as an independent biomarker of poor prognosis SAFIR02-Lung队列中肺腺癌的分子分析揭示了新的与转移相关的染色体拷贝数改变，包括频繁的突变特异性KRAS等位基因失衡，并将CDKN2A纯合子缺失鉴定为不良预后的独立生物标志物。

British Journal of Cancer

IF6.8

2025-09-11

PREAI

Abderaouf Hamza; Pierre Gestraud; Maryam Karimi; Alicia Tran-Dien; Laurène Syx; Sophie Vacher; Quentin Peretti; Ludovic Lacroix; Valery Attignon; Isabelle Soubeyran; Pascal Jézéquel; David Planchard; Samia Melaabi; Trenton Dailey-Chwalibóg; Marta Jimenez; Stefan Michiels; Nicolas Servant; Christophe Le Tourneau; Nicolas Girard; Fabrice André; Benjamin Besse; Maud Kamal; Fabrice Barlesi; Ivan Bièche

Identifying health conditions associated with an increased risk of pancreatic ductal adenocarcinoma at medium term in nationwide electronic health records of primary care physicians 识别与中期内胰腺导管腺癌风险增加相关的健康状况：基于全国初级保健医师电子健康记录的研究

British Journal of Cancer

IF6.8

2025-08-30

OAAI

Elie Rassy; Suzette Delaloge; Yannis Slaouti; Thomas Pudlarz; Béranger Lekens; Alice Boilève; Stefan Michiels; Mariam Karimi

Prognostic significance of early on-treatment evolution of circulating tumor DNA in advanced ER+/HER2- breast cancer 早期治疗期间循环肿瘤DNA的演变在晚期ER+/HER2-乳腺癌中的预后意义

Annals of Oncology

IF65.4

2025-07-05

PREAI

A. Mamann; Y. Pradat; F.C. Bidard; S. Delaloge; L. Cabel; I. Faull; S. Marques; T. Bachelot; F. Dalenc; T. de la Motte Rouge; B. Pistilli; J. Samaniego; J.S. Frenel; C. Levy; J.M. Ferrero; R. Sabatier; S. Ladoire; C. Chakiba; A.C. Hardy; J. Lemonnier; Y. Mahi; F. Andre; P.H. Cournede; S. Michiels; E. Bernard

Early toxicity of moderately hypofractionated radiation therapy in breast cancer patients receiving locoregional irradiation: First results of the UNICANCER HypoG-01 phase III trial 中度低分割放射疗法在同时接受局部区域照射的乳腺癌患者中的早期毒性：UNICANCER HypoG-01 III期试验的初步结果

RADIOTHERAPY AND ONCOLOGY

IF5.3

2025-06-01

PREAI

Brion, Thomas; Ghodssighassemabadi, Robabeh; Auzac, Guillaume; Kirova, Youlia; Benchalal, Mohamed; Clavier, Jean-Baptiste; Brunaud, Claire; Fouche-Chand, Marie-Eve; Argo-Leignel, Delphine; Peignaux-Casasnovas, Karine; Benyoucef, Ahmed; Pasquier, David; Guilbert, Philippe; Blanchecotte, Julien; Tallet-Richard, Agnes; Lamrani, Assia; Bergeau, Marie; Bielynite, Gabriele; Racadot, Severine; Ruffier, Amandine; Karamouza, Eleni; Michiels, Stefan; Rivera, Sofia

Short-term pre-operative durvalumab in early small triple negative breast cancer patients (POP-Durva)早期三阴性乳腺癌患者短期术前度伐利尤单抗治疗（POP-Durva）

ANNALS OF ONCOLOGY

IF65.4

2024-12-01

PREAI

Douglas, J. R. Dixon; Ribeiro, J. T. M. L.; Pic, I.; Blampey, Q.; Rassy, E.; Ibrahimi, N.; Salabert, L.; Tredan, O.; Arnedos, M.; Dogan, S.; Serhal, K.; Viansone, A. A.; Pistilli, B.; Lacroix-Triki, M.; Scoazec, J-Y.; Derosa, L.; Zitvogel, L.; Bercovici, N.; Andre, F.; Michiels, S.

A bio-behavioral model of systemic inflammation at breast cancer diagnosis and fatigue of clinical importance 2 years later 乳腺癌诊断中系统性炎症的生物行为模型和2年后临床重要性的乏力

ANNALS OF ONCOLOGY

IF65.4

2024-11-01

OAAI

Di Meglio, A.; Havas, J.; Pagliuca, M.; Franzoi, M. A.; Soldato, D.; Chiodi, C. K.; Gillanders, E.; Dubuisson, F.; Camara-Clayette, V.; Pistilli, B.; Ribeiro, J.; Joly, F.; Cottu, P. H.; Tredan, O.; Bertaut, A.; Ganz, P. A.; Bower, J.; Partridge, A. H.; Martin, A. L.; Everhard, S.; Boyault, S.; Brutin, S.; Andre, F.; Michiels, S.; Pradon, C.; Vaz-Luis, I.

The ESMO Tumour-Agnostic Classifier and Screener (ETAC-S): a tool for assessing tumour-agnostic potential of molecularly guided therapies and for steering drug development ESMO肿瘤不可知分类器和筛选器 (etac-s): 一种评估分子引导疗法的肿瘤不可知潜力和指导药物开发的工具

ANNALS OF ONCOLOGY

IF65.4

2024-11-01

OAAI

Westphalen, C. B.; Martins-Branco, D.; Beal, J. R.; Cardone, C.; Coleman, N.; Schram, A. M.; Halabi, S.; Michiels, S.; Yap, C.; Andre, F.; Bibeau, F.; Curigliano, G.; Garralda, E.; Kummar, S.; Kurzrock, R.; Limaye, S.; Loges, S.; Marabelle, A.; Marchio, C.; Mateo, J.; Rodon, J.; Spanic, T.; Pentheroudakis, G.; Subbiah, V.

Sustained lymphocyte decreases after treatment for early breast cancer

NPJ BREAST CANCER

IF7.6

2024-10-21

OAAI

Dixon-Douglas, Julia; Virassamy, Balaji; Clarke, Kylie; Hun, Michael; Luen, Stephen J.; Savas, Peter; van Geelen, Courtney T.; David, Steven; Francis, Prudence A.; Salgado, Roberto; Michiels, Stefan; Loi, Sherene

Deciphering resistance mechanisms in cancer: final report of MATCH-R study with a focus on molecular drivers and PDX development 破译癌症的耐药机制: MATCH-R研究的最终报告，重点是分子驱动和PDX的发展

MOLECULAR CANCER

IF33.9

2024-10-04

OAAI

Vasseur, Damien; Bigot, Ludovic; Beshiri, Kristi; Florez-Arango, Juan; Facchinetti, Francesco; Hollebecque, Antoine; Tselikas, Lambros; Aldea, Mihaela; Blanc-Durand, Felix; Gazzah, Anas; Planchard, David; Lacroix, Ludovic; Pata-Merci, Noemie; Nobre, Catline; Da Silva, Alice; Nicotra, Claudio; Ngo-Camus, Maud; Braye, Floriane; Nikolaev, Sergey I.; Michiels, Stefan; Jules-Clement, Gerome; Olaussen, Ken Andre; Andre, Fabrice; Scoazec, Jean-Yves; Barlesi, Fabrice; Ponce, Santiago; Soria, Jean-Charles; Besse, Benjamin; Loriot, Yohann; Friboulet, Luc

Understanding and Overcoming Resistance to Selective FGFR Inhibitors across FGFR2-Driven Malignancies 了解和克服FGFR2-Driven恶性肿瘤对选择性FGFR抑制剂的耐药性

CLINICAL CANCER RESEARCH

IF10.2

2024-09-03

OAAI

Facchinetti, Francesco; Loriot, Yohann; Braye, Floriane; Vasseur, Damien; Bahleda, Rastislav; Bigot, Ludovic; Barbe, Remy; Nobre, Catline; Combarel, David; Michiels, Stefan; Italiano, Antoine; Smolenschi, Cristina; Tselikas, Lambros; Scoazec, Jean-Yves; Ponce-Aix, Santiago; Besse, Benjamin; Andre, Fabrice; Olaussen, Ken A.; Hollebecque, Antoine; Friboulet, Luc

Locoregional hypo vs normofractionated RT in early breast cancer: 5 years results of the HypoG-01 phase III UNICANCER trial 局部区域低分割与常规分割放疗在早期乳腺癌中的比较：HypoG-01 III期UNICANCER试验的5年结果

ANNALS OF ONCOLOGY

IF65.4

2024-09-01

PREAI

Rivera, S.; Ghodssighassemabadi, R.; Brion, T.; Kirova, Y.; Racadot, S.; Benchalal, M.; Clavier, J. B.; Brunaud, C.; Fouche-Chand, M-E.; Leignel, D. Argo; Peignaux-Casasnovas, K.; Benyoucef, A.; Pasquier, D.; Guilbert, P.; Blanchecotte, J.; Phothirath, G.; Lamrani-Ghaouti, A.; Bergeaud, M.; Auzac, G.; Michiels, S.

Impact of concomitant co-medications on survival with first-line pembrolizumab in 43,000 French patients with advanced NSCLC 合并用药对43,000名法国晚期非小细胞肺癌患者接受一线帕博利珠单抗治疗生存期的影响

ANNALS OF ONCOLOGY

IF65.4

2024-09-01

PREAI

Rousseau, A.; Foulon, S.; Simon-Tillaux, N.; Michiels, S.; Lolivier, A.; Bonastre, J.; Planchard, D.; Barlesi, F.; Masip, J. Remon; Lavaud, P.; Aldea, M.; Frelaut, M.; Parisi, C.; Le Pechoux, C.; Botticella, A.; Levy, A.; Gazzah, A.; Besse, B.

研究方向